Stockreport

Zomedica Announces Achievement of Therapeutic Development Milestones

Zomedica Corp. Common Shares  (ZOM) 
US:NYSE Investor Relations: investors.zomedica.com
PDF ANN ARBOR, Mich., Dec. 12, 2017 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American:ZOM) (TSX-V:ZOM) (“Zomedica” or “Company”), a veterinary pharmaceutic [Read more]